UCB’s new chief executive Jean-Christophe Tellier has been selected to join the Ministerial Industry Strategy Group as group representative for European pharmaceutical companies.

The MISG was established to bring together government and the research-based bio-pharmaceutical industry to promote UK industry, drive strategic development, and foster a transparent relationship with the National Health Service to facilitate joint working. 

Commenting on his appointment, Jean-Christophe said he is “pleased to be sharing some of UCB’s experience as an inward R&D inward investor with the MISG, in an effort to shape a positive climate that incentivises innovation for the improvement of patient care.”

Co-chaired by the Secretary of State for Health and the chairman of the British Pharma Group, other MISG pharma representatives currently include AstraZeneca’s Pascal Soriot and GlaxoSmithKline’s Patrick Vallance, as well as members of various trade associations.